欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/7160/001
药品名称Plerixafor Teva 20 mg/ml solution for injection
活性成分
    • PLERIXAFOR 20.0 mg/ml
剂型Solution for injection
上市许可持有人Teva B.V. Swensweg 5 2031GA Haarlem Netherlands
参考成员国 - 产品名称Germany (DE)
Plerixafor-ratiopharm 20 mg/ml Injektionslösung
互认成员国 - 产品名称
    • Denmark (DK)
    • Slovenia (SI)
    • Belgium (BE)
    • Croatia (HR)
    • Netherlands (NL)
      Plerixafor Teva 20 mg/ml, oplossing voor injectie
    • Luxembourg (LU)
    • Iceland (IS)
    • Austria (AT)
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Hungary (HU)
许可日期2023/03/14
最近更新日期2023/07/11
药物ATC编码
    • L03AX16 plerixafor
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase